结核病与肺部健康杂志 ›› 2017, Vol. 6 ›› Issue (3): 246-249.doi: 10.3969/j.issn.2095-3755.2017.03.000

• 论著 • 上一篇    下一篇

结核患者外周血单核细胞检测的临床意义

范引梅,刘群群,苗艳芳,唐神结   

  1. 030053 太原市第四人民医院耐药结核二科(范引梅、刘群群、苗艳芳);首都医科大学附属北京胸科医院 北京市结核病胸部肿瘤研究所(唐神结)
  • 收稿日期:2017-03-27 出版日期:2017-09-30 发布日期:2017-09-30
  • 作者简介:唐神结

Clinical significance of peripheral blood mononuclear cells in tuberculosis patients

FAN Yin-mei, LIU Qun-qun, MIAO Yan-fang, TANG Shen-jie   

  1. No.2 Section of Drug-resistant tuberculosis, the Fourth People's Hospital of Taiyuan, Taiyuan 030053, China
  • Received:2017-03-27 Online:2017-09-30 Published:2017-09-30

摘要: 目的 探讨外周血单核细胞检测结果与结核病的关系。方法 选取2013年1月至2016年12月太原市第四人民医院确诊的痰结核分枝杆菌培养阳性的肺结核患者(肺结核组)150例、健康体检者(对照组)100名、肺癌患者(肺癌组)80例作为研究对象。将肺结核组又分为初治中青年组、初治老年组、复治中青年耐药组。收集研究对象入院时的单核细胞百分比及对照组体检时的单核细胞百分比,进行比较分析。 结果 肺结核组、对照组、肺癌组外周血单核细胞百分比差异有统计学意义(F=67.59,P<0.05),其中,肺结核组入院时单核细胞百分比为(10.8±2.94)%,高于对照组的(6.86±1.42)%(P<0.05)和肺癌组的(7.95±1.73)%(P<0.05)。初治中青年组入院时外周血单核细胞百分比为(10.80±2.72)%、初治老年组为(10.40±2.82)%、复治中青年耐药组为(10.52±3.22)%,三组差异无统计学意义(F=0.22,P=0.804)。结论 肺结核患者外周血单核细胞百分比增高。

Abstract: Objective To investigate the relationship between peripheral blood mononuclear cells (PBMC) and tuberculosis. Methods 150 tuberculosis patients (tuberculosis group), 80 lung cancer patients (lung cancer group) and 100 healthy volunteers (control group) screened from the Fourth People's Hospital of Taiyuan between January 2013 and December 2016 were included in the present study. The tuberculosis group was divided into the initially treated young subgroup, initially treated old subgroup and retreated young subgroup. The percentage of PBMC in the tuberculosis group and the lung cancer group when admitted to hospital and that in the control group form physical examination record were collected and compared. Results Significant difference in PBMC percentage among the three group was detected (F=67.59, P<0.05). The PBMC percentage in the tuberculosis group was (10.8±2.94)%, which was higher than that in the control group (6.86 ± 1.42)% and the lung cancer group (7.95 ± 1.73)% (P<0.05). The PBMC percentage in the initially treated young subgroup, initially treated old subgroup and retreated young subgroup was (10.80±2.72)%, (10.40 ± 2.82)% and (10.52 ± 3.22)%; but there was no statistically significant difference (F = 0.22, P = 0.804). Conclusion The percentage of PBMC in patients with pulmonary tuberculosis was increased.